Worth the effort? Not if you're depressed

August 12, 2009
Worth the effort? Not if you're depressed

Enlarge

Individuals suffering from anhedonia, a key symptom of depression, are less likely to pursue rewards if effort is required to obtain the reward. Credit: Michael Treadway, Vanderbilt University

New research indicates that decreased cravings for pleasure may be at the root of a core symptom of major depressive disorder. The research is in contrast to the long-held notion that those suffering from depression lack the ability to enjoy rewards, rather than the desire to seek them.

The research, led by Vanderbilt psychologists Michael Treadway and David Zald, was published Aug. 12 by the online journal .

"This initial study shows that decreased reward processing, which is a core symptom of depression, is specifically related to a reduced willingness to work for a reward," Treadway, a graduate student in psychology, said.

Decreased motivation to seek and experience pleasurable experiences, known as anhedonia, is a primary symptom of . Anhedonia is less responsive to many and often persists after other symptoms of depression subside. However, understanding the different components of anhedonia - the desire to obtain something pleasurable versus experiencing pleasure - has been difficult for researchers to determine in humans.

"In the last decade and a half, animal models have found that the dopamine, long known to be involved in reward processing, is involved in craving or motivation, but not necessarily enjoyment," Treadway said. "To date, research into reward processing in individuals with anhedonia has focused on enjoyment of rewards, rather than assessing the drive to work for them. We think this task is one of the first to do that."

Treadway and his colleagues devised the Effort-Expenditure for Rewards Task, or EEfRT, to explore the role of reduced desire and motivation in individuals reporting symptoms of anhedonia. EEfRT involved having individuals play a simple video game that gave them a chance to choose between two different tasks, one hard, one difficult, to obtain monetary rewards. Participants were eligible but not guaranteed to receive money each time they completed a task successfully.

The "hard" task required pressing a button 100 times within 21 seconds using one's non-dominant little finger and carried a potentially higher reward than the easy task, which required pressing a button 30 times in seven seconds using one's dominant index finger. The subjects were told at the beginning of each trial whether they had a high, medium or low probability of winning a prize if they successfully completed the trial. The participants could choose which trials they completed and were given 20 minutes to perform as many tasks as possible.

The researchers found that subjects who reported symptoms consistent with anhedonia where less willing to make choices requiring greater effort in exchange for greater reward, particularly when the rewards were uncertain.

"Consistent with our hypotheses, we found that individuals with self-reported anhedonia made fewer hard-task choices," the authors wrote. "These findings are consistent with theoretical models linking anhedonia to decreased (dopamine levels)."

"By addressing the motivational dimension of anhedonia, our findings suggest a plausible theoretical connection between dopamine deficiency and reward processing in , which may eventually help us better understand how anhedonia responds to treatment," Treadway said.

Source: Vanderbilt University (news : web)

4.6 /5 (19 votes)  

Filter


Move the slider to adjust rank threshold, so that you can hide some of the comments.


Display comments: newest first

zevkirsh
Aug 13, 2009

Rank: 5 / 5 (1)
i think i'll go smoke a ciggarette
david_42
Aug 13, 2009

Rank: 5 / 5 (1)
An interesting confirmation of my own experience with depression. Evaluation of depression always asks about enjoying activities. Why bother? prevents me from seeking out the activity in the first place.
Nik_2213
Aug 13, 2009

Rank: not rated yet
Yeah, like the other 'gotcha': Not Passive-Aggressive Condition, but old-fashioned 'Compliance Fatigue'...
finitesolutions
Aug 13, 2009

Rank: not rated yet
Quitting is also a decision: a hard one.
fuzz54
Aug 13, 2009

Rank: 5 / 5 (1)
My experience with anhedonia agrees with this article. None of the antidepressants really cured it except for one which worked on serotonin AND dopamine. Just serotonin or dopamine alone didn't do it. And of course I went to therapy to figure out what goals I should be working towards to actually make me happy once I had the motivation to fix things.
paulthebassguy
Aug 13, 2009

Rank: not rated yet
But in this test what was the most logical way to get the best reward? - Since you only had 20 minutes, wouldn't it be best to concentrate on the easier tasks where you had a more likely chance of getting a reward, in order to get the most amount of money at the end?
AMMBD
Aug 15, 2009

Rank: not rated yet
@fuzz54 - what was the name of that drug that worked? i would like to suggest my father's doctor look into it.
fuzz54
Oct 12, 2009

Rank: not rated yet
The drug I took that had serotonin and dopamine was Effexor XR. There is now a generic version of this drug available. Effexor can have significant withdrawl symptoms though, so it can be hard to get off of and can be awful if you forget a dose and don't have access to it. I'm not having any problems though and am successfully dropping my dosage with no side effects.
Rank 4.6 /5 (19 votes)
Relevant PhysicsForums posts
  • Is Everyday Technology Killing Us?
    createdFeb 08, 2012
  • Exercise and weight loss
    createdFeb 08, 2012
  • Why do we have head aches? Our brains can't feel anything.
    createdFeb 07, 2012
  • "The end of diseases" by David Agus, interview from Daily Show with Jon Stewart
    createdFeb 04, 2012
  • Oncolytic adenovirus
    createdFeb 04, 2012
  • Nutrition label stuffs and diets
    createdFeb 02, 2012
  • More from Physics Forums - Medical Sciences

More news stories

Curry spice component may help slow prostate tumor growth

Curcumin, an active component of the Indian curry spice turmeric, may help slow down tumor growth in castration-resistant prostate cancer patients on androgen deprivation therapy (ADT), a study from researchers ...

Medicine & Health / Cancer

created 14 minutes ago | popularity not rated yet | comments 0 | with audio podcast

Arthritic knees, but not hips, have robust repair response

Researchers at Duke University Medical Center used new tools they developed to analyze knees and hips and discovered that osteoarthritic knee joints are in a constant state of repair, while hip joints are not.

Medicine & Health / Diseases

created 24 minutes ago | popularity not rated yet | comments 0 | with audio podcast

To avoid early labor and delivery, weight and diet changes not the answer

One of the strongest known risk factors for spontaneous or unexpected preterm birth – any birth that occurs before the 37th week of pregnancy, most often without a known cause – is already having had one. For women ...

Medicine & Health / Health

created 34 minutes ago | popularity not rated yet | comments 0 | with audio podcast

Joint patent for using the BRCA1 gene as a therapy for cardiovascular disease

St. Michael's Hospital and King Saud University have received their first joint U.S. patent to use the BRCA1 gene as a therapy for cardiovascular disease.

Medicine & Health / Genetics

created 50 minutes ago | popularity not rated yet | comments 0

Orthopaedic surgery report provides transparency on patient safety, quality initiatives

At NYU Langone Medical Center the focus on quality, patient safety and patient experience are not just broad stroke initiatives – but measureable, quantifiable and concrete. Patients and health care professionals can ...

Medicine & Health / Other

created 49 minutes ago | popularity not rated yet | comments 0


Experts reveal how plants don't get sunburn

(PhysOrg.com) -- Experts at the University of Glasgow have discovered how plants survive the harmful rays of the sun.

Fool's gold may prove an unlikely alternative to overexploited catalytic materials

Catalytic materials, which lower the energy barriers for chemical reactions, are used in everything from the commercial production of chemicals to catalytic converters in car engines. However, with current catalytic materials ...

Unpicking HIV’s invisibility cloak

Drug researchers hunting for alternative ways to treat human immunodeficiency virus (HIV) infections may soon have a novel target—its camouflage coat. HIV hides inside a cloak unusually rich in a sugar ...

What lies beneath: Mapping hidden nanostructures

The ability to diagnose and predict the properties of materials is vital, particularly in the expanding field of nanotechnology. Electron and atom-probe microscopy can categorize atoms in thin sheets of material, ...

Netflix light on flicks as viewers soak up TV shows

Like most fresh faces that arrive in Hollywood, Netflix wanted to be a movie star. But now it's learning what many in Tinseltown have known for decades: Movies are sexy, but the real money is in television.

Sony's Hirai refuses to abandon dire TV business

Struggling Japanese entertainment giant Sony will not abandon its cash-bleeding television business, its incoming CEO says, but he acknowledges tough decisions lie ahead including over redundancies.